Two Sigma Investments’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Other funds holding AVIR
BCM
Two Sigma Investments's AVIR Position: Q3 2026 in Review
Two Sigma Investments reduced its Atea Pharmaceuticals (AVIR) stake by 13% in Q3 2026, selling an estimated $1.04M and leaving 1,303,341 shares worth $6.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1874.
Two Sigma Investments first reported a position in AVIR in Q4 2021 and has held it in 18 quarters since. The position peaked at $10M in Q1 2026. 124 funds tracked by Wall St. Rank hold AVIR as of Q3 2026.
- Two Sigma Investments held 1,303,341 shares of Atea Pharmaceuticals worth $6.79M as of Q3 2026.
- Two Sigma Investments sold 203,356 Atea Pharmaceuticals shares in Q3 2026, an estimated $1.04M.
- Atea Pharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #1874 holding.
- Two Sigma Investments first reported a position in Atea Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
- Two Sigma Investments's Atea Pharmaceuticals position peaked at $10M in Q1 2026.
- 124 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.